Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing.
Regenerative Bio has raised $10.0M in total funding. The most recent round was Angel. The last funding was announced in February 2022.
Regenerative Bio's investors include UpHonest Capital, 5Y Capital, K2VC, Taihill Venture, IMO Ventures.
Regenerative Bio is headquartered in Cambridge, United States.
Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing.
Regenerative Bio is at the Angel stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Regenerative Bio — Funding & Investors." VCBacked, February 25, 2022, https://www.vcbacked.co/company/regenerative-bio. Accessed September 11, 2026.
VCBacked. (2022). Regenerative Bio — Funding & Investors. Retrieved September 11, 2026, from https://www.vcbacked.co/company/regenerative-bio
{{cite web |title=Regenerative Bio — Funding & Investors |url=https://www.vcbacked.co/company/regenerative-bio |website=VCBacked |access-date=September 11, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated